These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25510663)

  • 1. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
    Liu T; Qin W; Hou L; Huang Y
    Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
    Zeng PY; Berger SL
    Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
    Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
    Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.
    He Z; Chen J; Chen X; Wang H; Tang L; Han C
    J Cell Physiol; 2021 Jan; 236(1):107-120. PubMed ID: 33459391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
    Cheng W; Liu T; Wan X; Gao Y; Wang H
    FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
    Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B
    Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.
    Pan Y; Zhang L; Zhang X; Liu R
    Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation.
    Hou X; Liu JE; Liu W; Liu CY; Liu ZY; Sun ZY
    Oncogene; 2011 Jun; 30(26):2933-42. PubMed ID: 21317932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1).
    Tiainen M; Vaahtomeri K; Ylikorkala A; Mäkelä TP
    Hum Mol Genet; 2002 Jun; 11(13):1497-504. PubMed ID: 12045203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a.
    Cho JG; Park S; Lim CH; Kim HS; Song SY; Roh TY; Sung JH; Suh W; Ham SJ; Lim KH; Park SG
    Oncotarget; 2016 May; 7(21):31177-90. PubMed ID: 27105517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
    Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
    Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
    Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
    Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
    Yi C; Wang Q; Wang L; Huang Y; Li L; Liu L; Zhou X; Xie G; Kang T; Wang H; Zeng M; Ma J; Zeng Y; Yun JP
    Oncogene; 2012 Oct; 31(41):4421-33. PubMed ID: 22249270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.